STOCK EXCHANGE AND LOAN AGREEMENTStock Exchange and Loan Agreement • April 12th, 2022 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Colorado
The undersigned (“Investor”) hereby agrees to exchange all of his shares of Series E Redeemable Convertible Preferred Stock (the “Series E Shares”) in Navidea Biopharmaceuticals, Inc., a Delaware corporation with an address of 4995 Bradenton Ave #240, Dublin, OH 43017 (the “Company”) for other shares in two separate classes of preferred stock and as inducement to loan the Company certain funds as set forth in this Stock Exchange and Loan Agreement (“Agreement”), which is subject to the following terms and conditions:
